Technical Analysis for PETX - Aratana Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 4.92 -0.20% -0.01
PETX closed down 0.2 percent on Wednesday, July 17, 2019, on 12.05 times normal volume. It was able to find support at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Earnings due: Oct 30

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical PETX trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
50 DMA Support Bullish 0.00%
Volume Surge Other 0.00%
Inside Day Range Contraction 0.00%
20 DMA Resistance Bearish -0.20%
Fell Below 200 DMA Bearish -0.20%
50 DMA Support Bullish -0.20%
Volume Surge Other -0.20%
Lower Bollinger Band Touch Weakness -0.20%
20 DMA Resistance Bearish -2.77%

Older signals for PETX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Medicine Health Biopharmaceutical Pain Surgery Medication Inflammation Osteoarthritis Arthritis Aging Associated Diseases Rheumatology Skeletal Disorders
Is PETX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.16
52 Week Low 3.3
Average Volume 744,019
200-Day Moving Average 4.9928
50-Day Moving Average 4.9082
20-Day Moving Average 5.073
10-Day Moving Average 5.044
Average True Range 0.1573
ADX 17.73
+DI 15.179
-DI 23.9189
Chandelier Exit (Long, 3 ATRs ) 4.8281
Chandelier Exit (Short, 3 ATRs ) 5.1823
Upper Bollinger Band 5.2744
Lower Bollinger Band 4.8716
Percent B (%b) 0.12
BandWidth 7.940075
MACD Line 0.034
MACD Signal Line 0.0726
MACD Histogram -0.0386
Fundamentals Value
Market Cap 211.57 Million
Num Shares 43 Million
EPS -1.61
Price-to-Earnings (P/E) Ratio -3.06
Price-to-Sales 26.68
Price-to-Book 2.44
PEG Ratio -0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.12
Resistance 3 (R3) 5.12 5.07 5.08
Resistance 2 (R2) 5.07 5.02 5.06 5.07
Resistance 1 (R1) 4.99 4.99 4.97 4.99 5.06
Pivot Point 4.94 4.94 4.92 4.93 4.94
Support 1 (S1) 4.86 4.89 4.84 4.86 4.78
Support 2 (S2) 4.81 4.86 4.80 4.77
Support 3 (S3) 4.73 4.81 4.76
Support 4 (S4) 4.73